Deuterated drugs: where are we now?

Bibliography

• Reinhold DF. Processes for asymmetric conversion of 3-fluoro-L-alanine and 2-deutero-3-fluoro-L-alanine to their D-isomers. US3950411; 1976
   Google Scholar
• McCarty LP. Compositions and methods for anesthetizing an animal using deuterated analogues of halothane and chloroform. US4069346; 1978
   Google Scholar
• Buteau KC. Deuterated drugs: unexpectedly nonobvious. J High Tech L 2009;10:22
   Google Scholar
• Gant TG. Using deuterium in drug discovery: leaving the label in the drug. J Med Chem 2013;57(9):3595-611
   PubMedGoogle Scholar
• Darland GK, Hajdu R, Kropp H, et al. Oxidative and defluorinative metabolism of fludalanine, 2-2H-3-fluoro-D-alanine. Drug Metab Dispos 1986;14(6):668-73
   Google Scholar
• Larsen ER, McCarty LP. Deuterated 1,1-difluoro-2,2-dihaloethyl difluoromethyl ethers. US4154971; 1979
   Google Scholar
• Larsen ER, McCarty LP. Deuterated 1,1-difluoro-2,2-dihaloethyl difluoromethyl esters. US4188405; 1980
   Google Scholar
• Baker MT, Tinker JH. Deuterated sevoflurane as an inhalational anesthetic. US5391579; 1995
   Google Scholar
• Baker MT, Tinker JH. Deuterated sevoflurane as an inhalational anesthetic. US5789450; 1998
   Google Scholar
• Caille G, Foster RT, Lewanczuk R. Enhancement of the efficacy of nifedipine by deuteration. US5846514; 1998
   Google Scholar
• Naicker S, Yatscoff RW, Foster RT. Methods of making deuterated cyclosporin analogs. US7538189; 2009
   Google Scholar
• Sanderson K. Big interest in heavy drugs. Nature 2009;458(7236):269
   PubMed Web of Science ®Google Scholar
• Katsnelson A. Heavy drugs draw heavy interest from pharma backers. Nat Med 2013;19(6):656
   PubMed Web of Science ®Google Scholar
• Rao T, Zhang C. Cyclopropyl modulators of p2y12 receptor. US20120301458; 2012
   Google Scholar
• Dyck LE, Durden DA, Boulton AA. Effects of deuterium substitution on the catabolism of beta-phenylethylamine: an in vivo study. J Neurochem 1986;46(2):399-404
   Google Scholar
• Dewar KM, Dyck LE, Durden DA, et al. Effect of deuterium substitution on the penetration of beta-phenylethylhydrazine into the rat brain. Biochem Pharmacol 1988;37(13):2703-4
   Google Scholar
• Dyck LE, Boulton AA. Effect of deuterium substitution on the disposition of intraperitoneal tryptamine. Biochem Pharmacol 1986;35(17):2893-6
   Google Scholar
• Ando K, Kawamura K. Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents. US6603008; 2003
   Google Scholar
• Foster RT. Method of using deuterated calcium channel blockers. US6221335; 2001
   Google Scholar
• Gant TG, Sarshar S. Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties. US20070082929; 2007
   Google Scholar
• Ito N, Maesawa T, Muto K, et al. Method for deuteration of a heterocyclic ring. US7517990B2; 2009
   Google Scholar
• Kushner D, Baker A, Dunstall T. Pharmacological uses and perspectives of heavy water and deuterated compounds. Can J Physiol Pharmacol 1999;77(2):79-88
   Google Scholar
• Poyten MC, Josyula KVB, Gao P, et al. Stabilized deuteroborane-tetrahydrofuran complex. US20070197695; 2007
   Google Scholar
• Baillie TA. The use of stable isotopes in pharmacological research. Pharmacol Rev 1981;33(2):81-132
   PubMed Web of Science ®Google Scholar
• Browne TR. Stable isotope techniques in early drug development: an economic evaluation. J Clin Pharmacol 1998;38(3):213-20
   Google Scholar
• Cherrah Y, Falconnet J, Desage M, et al. Study of deuterium isotope effects on protein binding by gas chromatography/mass spectrometry. Caffeine and deuterated isotopomers. Biol Mass Spectrom 1987;14(11):653-7
   Google Scholar
• Gouyette A. Synthesis of deuterium-labelled elliptinium and its use in metabolic studies. Biol Mass Spectrom 1988;15(5):243-7
   Google Scholar
• Haskins N. The application of stable isotopes in biomedical research. Biol Mass Spectrom 1982;9(7):269-77
   Google Scholar
• Pieniaszek HJ, Mayersohn M, Adams MP, et al. Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications. J Clin Pharmacol 1999;39(8):817-25
   Google Scholar
• Tonn G, Mutlib A, Abbott F, et al. Simultaneous analysis of diphenhydramine and a stable isotope analog (2H10) diphenhydramine using capillary gas chromatography with mass selective detection in biological fluids from chronically instrumented pregnant ewest. Biol Mass Spectrom 1993;22(11):633-42
   Google Scholar
• Wolen RL. The application of stable isotopes to studies of drug bioavailability and bioequivalence. J Clin Pharmacol 1986;26(6):419-24
   Google Scholar
• Tung RD, Morgan AJ, Silverman IR. 4-hydroxybutyric acid analogs. US20130012565; 2013
   Google Scholar
• Czarnik AW. Deuterium-enriched bupropion. US8524780; 2013
   Google Scholar
• Liu JF, Tung RD. Substituted dioxopiperidinyl phthalimide derivatives. US20130150408; 2013
   Google Scholar
• Cederstav AK, Novak BM. Investigations into the chemistry of thermodynamically unstable species. The direct polymerization of vinyl alcohol, the enolic tautomer of acetaldehyde. J Am Chem Soc 1994;116(9):4073-4
   Google Scholar
• Braman V, Graham P, Cheng C, et al. A randomized phase I evaluation of CTP-499, a novel deuterium-containing drug candidate for diabetic nephropathy. Clinical Pharmacology in Drug Development 2013;2(1):53-66
   Google Scholar
• Sharma R, Strelevitz TJ, Gao H, et al. Deuterium isotope effects on drug pharmacokinetics. I. System-dependent effects of specific deuteration with aldehyde oxidase cleared drugs. Drug Metab Dispos 2012;40(3):625-34
   PubMed Web of Science ®Google Scholar
• Manley PW, Blasco F, Mestan J, et al. The kinetic deuterium isotope effect as applied to metabolic deactivation of imatinib to the des-methyl metabolite, CGP74588. Bioorg Med Chem 2013;21(11):3231-9
   PubMed Web of Science ®Google Scholar
• Jones AD, Paul BJ. Method of utilizing recycled deuterium oxide in the synthesis of deuterated compounds. US20140046060; 2014
   Google Scholar
• Harbeson SL. Substituted triazolophthalazine derivatives. US20140024652; 2014
   Google Scholar
• Tung RD. Deuterated benzo[d][1,3]-dioxol derivatives. US20140018390; 2014
   Google Scholar
• Tung R, Masse CE. Pyrimidine derivatives. US20140018379; 2014
   Google Scholar
• Pandya B, Masse CE, Silverman IR, et al. Derivatives of pyrazole-substituted amino-heteroaryl compounds. US20140005211; 2014
   Google Scholar
• Liu JF. Substituted isoindoline-1,3-dione derivatives. US20130345282; 2013
   Google Scholar
• Harbeson SL, Tung R, Liu JF. Substituted triazolo-pyridazine derivatives. US20130317033; 2013
   Google Scholar
• Tung R. Morphinan compounds. US20130310415; 2013
   Google Scholar
• Harbeson SL. Substituted triazolo-pyridazine derivatives. US20130225590; 2013
   Google Scholar
• Tung R. Substituted dioxopiperidinyl phthalimide derivaties. WO2010056344; 2010
   Google Scholar
• Persichetti RA, Liu JF, Masse CE, et al. Analogues of cilostazol. US20130131021; 2013
   Google Scholar
• Harbeson SL, Liu JF, Tung R. N-phenyl-2-pyrimidineamine derivatives. US20130121963; 2013
   Google Scholar
• Persichetti RA, Liu JF. Fluorouracil derivatives. US20130109707; 2013
   Google Scholar
• Tung R. Novel pyrimidinecarboxamide derivatives. US20130109660; 2013
   Google Scholar
• Tung RD. Heterocyclic kinase inhibitors. US20130095100; 2013
   Google Scholar
• Czarnik AW. Deuterium-enriched dasatinib. US20090076025; 2009
   Google Scholar
• Liu JF, Tung R, Harbeson SL. Pyrazinoisoquinoline compounds. US20130029997; 2013
   Google Scholar
• Tung RD, Masse CE. Substituted derivatives of bicyclic [4.3.0] heteroaryl compounds. US20120295925; 2012
   Google Scholar
• Masse CE, Harbeson SL, Tung RD. Prostacyclin derivatives. US20120270934; 2012
   Google Scholar
• Liu JF, Persichetti RA. Analogues of cilostazol. US20120264721; 2012
   Google Scholar
• Liu JF. Substituted isoindoline-1,3-dione derivatives. US20120252864; 2012
   Google Scholar
• Liu JF, Tung RD, Harbeson SL. Fluorinated diaryl urea derivatives. US20120237474; 2012
   Google Scholar
• Tung RD, Liu JF, Harbeson SL. Substituted xanthine derivatives. US20120202830; 2012
   Google Scholar
• Armstrong R, Watson J, Yeadon M. Combination of a PDE4 inhibitor and tiotropium or derivative thereof for treating obstructive airways and other inflammatory diseases. US20050107420; 2005
   Google Scholar
• Liu JF, Tung R, Harbeson SL. Pyrazinoisoquinoline compounds. US20120149709; 2012
   Google Scholar
• Liu JF, Persichetti RA. Deuterated fingolimod. US20120141513; 2012
   Google Scholar
• Gant TG, Zhang C, Shahbaz M. Benzoquinolone inhibitors of vmat2. US20120003330; 2012
   Google Scholar
• Rao T, Zhang C. Benzazepine inhibitors of gamma-secretase. US20110306596; 2011
   Google Scholar
• Rao T, Zhang C. Pyrimidinone inhibitors of lipoprotein-associated phospholipase a2. US20110306552; 2011
   Google Scholar
• Rao T, Zhang C. 3,4-methylenedioxyphenyl inhibitors of gaba aminotransferase and/or gaba reuptake transporter inhibitor. US20110257260; 2011
   Google Scholar
• Zhang C. Piperidine modulators of dopamine receptor. US20110206782; 2011
   Google Scholar
• Gant TG, Sarshar S, Zhang C. Morphinan modulators of nmda receptors, sigma1 receptors, sigma2 receptors, and/or a3b4 nicotinic receptors. US20110206780; 2011
   Google Scholar
• Tung R. Morphinan compounds. US20080280936; 2008
   Google Scholar
• Zhang C, Sommer A. Trimethoxyphenyl inhibitors of tyrosine kinase. US20110206661; 2011
   Google Scholar
• Rao T, Zhang C. 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase. US20110201626; 2011
   Google Scholar
• Zhang C. Quinoline inhibitors of tyrosine kinase. US20110195066; 2011
   Google Scholar
• Czarnik AW. Deuterium-enriched bupropion. US20140018436; 2014
   Google Scholar
• Czarnik AW. Deuterium-enriched lenalidomide. US20130245067; 2013
   Google Scholar
• Czarnik AW. Deuterium-enriched donepezil. US20130090357; 2013
   Google Scholar
• DeWitt S. 3-deutero-pomalidomide. US20120302605; 2012
   Google Scholar
• DeWitt S. 2,6-dioxo-3-deutero-piperdin-3-yl-isoindoline compounds. US20120252844; 2012
   Google Scholar
• Czarnik AW. Deuterium-enriched ruboxistaurin. US20120136037; 2012
   Google Scholar
• Czarnik AW. Deuterium-enriched meropenem. US20120122833; 2012
   Google Scholar
• Czarnik AW. Deuterium-enriched ixabepilone. US20120035227; 2012
   Google Scholar
• Czarnik AW. Deuterium-enriched dasatinib. US20120015956; 2012
   Google Scholar
• Czarnik AW. Deuterium-enriched alogliptin. US20110312983; 2011
   Google Scholar
• Czarnik AW. Deuterium-enriched tolterodine. US20110281952; 2011
   Google Scholar
• Czarnik AW. Deuterium-enriched doripenem. US20110281927; 2011
   Google Scholar
• Czarnik AW. Deuterium-enriched risperidone. US20110212976; 2011
   Google Scholar
• Czarnik AW. Deuterium-enriched dapoxetine. US20110201690; 2011
   Google Scholar
• Lowe J. Benzophenones and sulfones as inhibitors of glycine uptake. US20020052401; 2002
   Google Scholar
• Eggenweiler HM, Wolf M. Pyridazine derivatives. US20050176714; 2005
   Google Scholar
• Eatherton A. Pyrimidine derivatives and their use as CB2 modulators. US20060293354; 2006
   Google Scholar
• Gu J, Ruppen M. 41-Methoxy isotope labeled rapamycin 42-ester. US20070105888; 2007
   Google Scholar
• McCarthy C, Press NJ. Organic compounds. US20090023769; 2009
   Google Scholar
• Grahames C, Mallinder P, McIntosh F, et al. Assays for allosteric modulators of G-protein coupled receptors (GPCRs). US20090305321; 2009
   Google Scholar
• Castanedo GM, Gunzner JL, Malesky K, et al. Thiazolopyrimidine p13k inhibitor compounds and methods of use. US20090118275; 2009
   Google Scholar
• Vasudevan A, Brown BS, Keddy RG, et al. Compounds useful as inhibitors of protein kinases. US20100035919; 2010
   Google Scholar
• Pracitto R, Kadow JF, Bender JA, et al. Compounds for the treatment of hepatitis C. US20100184800; 2010
   Google Scholar
• Putnam AMAH, Knudsen N, Norman T, et al. Modified bovine G-CSF polypeptides and their uses. US20100035812; 2010
   Google Scholar
• Follmann M, Stasch JP, Redlich G, et al. Substituted 5-fluoro-1H-pyrazolopyridines and their use. US20120022084; 2012
   Google Scholar
• Babin D, Bedel O, Gouyon T, et al. 9h-pyrrolo[2,3-b: 5,4-c’] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof. US20120208809; 2012
   Google Scholar
• Gong Y, Zinser HB. Process for the preparation of sulfamide derivatives. US20130085176; 2013
   Google Scholar